Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Adipokines in anorexia nervosa: A systematic review and meta-analysis.

Karageorgiou V, Furukawa TA, Tsigkaropoulou E, Karavia A, Gournellis R, Soureti A, Bellos I, Douzenis A, Michopoulos I.

Psychoneuroendocrinology. 2019 Oct 16;112:104485. doi: 10.1016/j.psyneuen.2019.104485. [Epub ahead of print] Review.

PMID:
31805456
2.

Use of social networking sites and desire for slimness among 10-year-old girls and boys: A population-based birth cohort study.

Sugimoto N, Nishida A, Ando S, Usami S, Toriyama R, Morimoto Y, Koike S, Yamasaki S, Kanata S, Fujikawa S, Furukawa TA, Sasaki T, Hiraiwa-Hasegawa M, Kasai K.

Int J Eat Disord. 2019 Nov 19. doi: 10.1002/eat.23202. [Epub ahead of print]

PMID:
31743492
3.

Influence diagnostics and outlier detection for meta-analysis of diagnostic test accuracy.

Matsushima Y, Noma H, Yamada T, Furukawa TA.

Res Synth Methods. 2019 Nov 14. doi: 10.1002/jrsm.1387. [Epub ahead of print]

PMID:
31724796
4.

Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis.

Fujii T, Belletti A, Carr A, Furukawa TA, Luethi N, Putzu A, Sartini C, Salanti G, Tsujimoto Y, Udy AA, Young PJ, Bellomo R.

BMJ Open. 2019 Nov 12;9(11):e033458. doi: 10.1136/bmjopen-2019-033458.

5.

Why has prevalence of mental disorders not decreased as treatment has increased?

Furukawa TA, Kessler RC.

Aust N Z J Psychiatry. 2019 Dec;53(12):1143-1144. doi: 10.1177/0004867419886652. Epub 2019 Nov 7. No abstract available.

PMID:
31696732
6.

No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.

Tsujimoto Y, Fujii T, Onishi A, Omae K, Luo Y, Imai H, Takahashi S, Itaya T, Pinson C, Nevitt SJ, Furukawa TA.

J Clin Epidemiol. 2019 Oct 22. pii: S0895-4356(19)30473-1. doi: 10.1016/j.jclinepi.2019.10.004. [Epub ahead of print]

PMID:
31654789
7.

Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation.

Omae K, Kataoka Y, Tsujimoto Y, Tsutsumi Y, Yamamoto Y, Fukuhara S, Furukawa TA.

BMC Cancer. 2019 Oct 24;19(1):998. doi: 10.1186/s12885-019-6232-x.

8.

An epidemic or a plague of common mental disorders?

Furukawa TA.

Acta Psychiatr Scand. 2019 Nov;140(5):391-392. doi: 10.1111/acps.13108. No abstract available.

PMID:
31650531
9.

Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol.

Tomlinson A, Furukawa TA, Efthimiou O, Salanti G, De Crescenzo F, Singh I, Cipriani A.

Evid Based Ment Health. 2019 Oct 23. pii: ebmental-2019-300118. doi: 10.1136/ebmental-2019-300118. [Epub ahead of print]

10.

Responses to depressive symptom items exhibit a common mathematical pattern across the European populations.

Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Ono Y, Furukawa TA.

Sci Rep. 2019 Oct 17;9(1):14923. doi: 10.1038/s41598-019-51499-w.

11.

Trajectory of criterion symptoms of major depression under newly started antidepressant treatment: sleep disturbances and anergia linger on while suicidal ideas and psychomotor symptoms disappear early.

Tajika A, Furukawa TA, Inagaki M, Kato T, Mantani A, Kurata K, Ogawa Y, Takeshima N, Hayasaka Y, Noma H, Maruo K.

Acta Psychiatr Scand. 2019 Dec;140(6):532-540. doi: 10.1111/acps.13115. Epub 2019 Nov 2.

PMID:
31618446
12.

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis.

Ostinelli EG, D'Agostino A, Shokraneh F, Salanti G, Furukawa TA.

BMJ Open. 2019 Oct 10;9(10):e032726. doi: 10.1136/bmjopen-2019-032726.

13.

Optimal dosing of antidepressant drugs - Authors' reply.

Furukawa TA, Cowen PJ, Salanti G, Leucht S, Egger M, Cipriani A.

Lancet Psychiatry. 2019 Oct;6(10):806-807. doi: 10.1016/S2215-0366(19)30339-6. No abstract available.

PMID:
31544758
14.

The association between role model presence and self-regulation in early adolescence: A cross-sectional study.

Nakanishi M, Yamasaki S, Endo K, Ando S, Morimoto Y, Fujikawa S, Kanata S, Takahashi Y, Furukawa TA, Richards M, Hiraiwa-Hasegawa M, Kasai K, Nishida A.

PLoS One. 2019 Sep 19;14(9):e0222752. doi: 10.1371/journal.pone.0222752. eCollection 2019.

15.

Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: Study protocol for a randomized, parallel-group, non-inferiority trial.

Yokoi Y, Nakagawa A, Yoshimura N, Furukawa TA, Mimura M, Iwanami A, Abe T, Nakagome K.

Neuropsychopharmacol Rep. 2019 Dec;39(4):262-272. doi: 10.1002/npr2.12078. Epub 2019 Sep 18.

16.

Whose depression deteriorates during acute phase antidepressant treatment?

Akechi T, Sugishita K, Chino B, Itoh K, Ikeda Y, Shimodera S, Yonemoto N, Miki K, Ogawa Y, Takeshima N, Kato T, Furukawa TA.

J Affect Disord. 2020 Jan 1;260:342-348. doi: 10.1016/j.jad.2019.09.052. Epub 2019 Sep 9.

PMID:
31521872
17.

A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study.

Tada M, Azuma H, Yamada N, Kano KI, Nagai H, Maeda S, Ishida H, Aoyama T, Okada R, Kawano T, Kobuchi T, Uzui H, Matano H, Iwasaki H, Maeno K, Shimada Y, Yoshida H, Ando M, Murakami Y, Iwakami N, Kishimoto S, Iwami T, Tada H, Chapman A, Mills N, Hayashi H, Furukawa TA, Watanabe N.

BMJ Open. 2019 Sep 3;9(9):e026985. doi: 10.1136/bmjopen-2018-026985.

18.

Certolizumab pegol for induction of remission in Crohn's disease.

Yamazaki H, So R, Matsuoka K, Kobayashi T, Shinzaki S, Matsuura M, Okabayashi S, Kataoka Y, Tsujimoto Y, Furukawa TA, Watanabe N.

Cochrane Database Syst Rev. 2019 Aug 29;8:CD012893. doi: 10.1002/14651858.CD012893.pub2.

PMID:
31476018
19.

Distribution of psychological distress is stable in recent decades and follows an exponential pattern in the US population.

Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Ono Y, Furukawa TA.

Sci Rep. 2019 Aug 19;9(1):11982. doi: 10.1038/s41598-019-47322-1.

20.

Development and validation of the Japanese version of the problem gambling severity index.

So R, Matsushita S, Kishimoto S, Furukawa TA.

Addict Behav. 2019 Nov;98:105987. doi: 10.1016/j.addbeh.2019.05.011. Epub 2019 May 13.

PMID:
31415969
21.

Permutation inference methods for multivariate meta-analysis.

Noma H, Nagashima K, Furukawa TA.

Biometrics. 2019 Aug 10. doi: 10.1111/biom.13134. [Epub ahead of print]

PMID:
31399994
22.

Why some depressive patients perform suicidal acts and others do not.

Akechi T, Kato T, Fujise N, Yonemoto N, Tajika A, Furukawa TA; SUN☺D Investigators.

Psychiatry Clin Neurosci. 2019 Oct;73(10):660-661. doi: 10.1111/pcn.12918. Epub 2019 Aug 26. No abstract available.

PMID:
31355505
23.

Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis.

Schneider-Thoma J, Efthimiou O, Bighelli I, Dörries C, Huhn M, Krause M, Reichelt L, Röder H, Furukawa TA, Davis JM, Leucht S.

Lancet Psychiatry. 2019 Sep;6(9):753-765. doi: 10.1016/S2215-0366(19)30223-8. Epub 2019 Jul 15.

PMID:
31320283
24.

Baseline severity and efficacy of antidepressants: into the third generation of research.

Furukawa TA.

Lancet Psychiatry. 2019 Sep;6(9):715-716. doi: 10.1016/S2215-0366(19)30249-4. Epub 2019 Jul 11. No abstract available.

PMID:
31303568
25.

Statistical significance did not affect time to publication in non-Cochrane systematic reviews: a metaepidemiological study.

Tsujimoto Y, Tsutsumi Y, Kataoka Y, Tsujimoto H, Yamamoto Y, Papola D, Guyatt GH, Fukuhara S, Furukawa TA.

J Clin Epidemiol. 2019 Nov;115:25-34. doi: 10.1016/j.jclinepi.2019.06.015. Epub 2019 Jul 2.

PMID:
31276781
26.

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G.

Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6.

27.

Guided or self-guided internet-based cognitive-behavioural therapy (iCBT) for depression? Study protocol of an individual participant data network meta-analysis.

Karyotaki E, Furukawa TA, Efthimiou O, Riper H, Cuijpers P.

BMJ Open. 2019 Jun 5;9(6):e026820. doi: 10.1136/bmjopen-2018-026820.

28.

Antidepressants plus benzodiazepines for adults with major depression.

Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, Furukawa TA.

Cochrane Database Syst Rev. 2019 Jun 3;6:CD001026. doi: 10.1002/14651858.CD001026.pub2.

PMID:
31158298
29.

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.

Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A.

BMJ Open. 2019 May 19;9(5):e027574. doi: 10.1136/bmjopen-2018-027574.

30.

Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD).

Yamada T, Nakaaki S, Sato J, Sato H, Shikimoto R, Furukawa TA, Mimura M, Akechi T.

Psychogeriatrics. 2019 Apr 24. doi: 10.1111/psyg.12459. [Epub ahead of print]

PMID:
31020753
31.

Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.

Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A.

Evid Based Ment Health. 2019 May;22(2):61-66. doi: 10.1136/ebmental-2019-300087. Epub 2019 Apr 17.

PMID:
30996028
32.

Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-analysis.

Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA.

JAMA Psychiatry. 2019 Jul 1;76(7):700-707. doi: 10.1001/jamapsychiatry.2019.0268. Erratum in: JAMA Psychiatry. 2019 Jul 17;:.

PMID:
30994877
33.

Association between patients' feedback comments and depressive mood, satisfaction, homework conducted, and dropouts during self-guided smartphone cognitive behavioral therapy.

Imai H, Takeshima N, Hayasaka Y, Yonemoto N, Ogawa Y, Tajika A, Fujita H, Kato T, Furukawa TA; FLATT Investigators.

Psychiatry Clin Neurosci. 2019 Jun;73(6):349-350. doi: 10.1111/pcn.12849. Epub 2019 Apr 29. No abstract available.

PMID:
30968499
34.

Further evidence that item responses on the Kessler Psychological Distress Scale exhibit the characteristic pattern in the general population.

Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Ono Y, Furukawa TA.

Heliyon. 2019 Mar 21;5(3):e01387. doi: 10.1016/j.heliyon.2019.e01387. eCollection 2019 Mar.

35.

Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: A randomized controlled trial✰✰.

Watanabe N, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA.

J Affect Disord. 2019 May 15;251:186-194. doi: 10.1016/j.jad.2019.03.067. Epub 2019 Mar 22.

PMID:
30927579
36.

Benzodiazepines versus placebo for panic disorder in adults.

Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD010677. doi: 10.1002/14651858.CD010677.pub2.

PMID:
30921478
37.

Cohort Profile: The Tokyo Teen Cohort study (TTC).

Ando S, Nishida A, Yamasaki S, Koike S, Morimoto Y, Hoshino A, Kanata S, Fujikawa S, Endo K, Usami S, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K; TTC Scientific and Data Collection Team.

Int J Epidemiol. 2019 Oct 1;48(5):1414-1414g. doi: 10.1093/ije/dyz033. No abstract available.

38.

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.

Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A.

J Affect Disord. 2019 May 1;250:419-424. doi: 10.1016/j.jad.2019.03.031. Epub 2019 Mar 6.

PMID:
30878654
39.

Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.

Furukawa TA, Reijnders M, Kishimoto S, Sakata M, DeRubeis RJ, Dimidjian S, Dozois DJA, Hegerl U, Hollon SD, Jarrett RB, Lespérance F, Segal ZV, Mohr DC, Simons AD, Quilty LC, Reynolds CF, Gentili C, Leucht S, Engel RR, Cuijpers P.

Epidemiol Psychiatr Sci. 2019 Mar 14:1-13. doi: 10.1017/S2045796019000088. [Epub ahead of print]

PMID:
30867082
40.

Predicting relapse in major depression after successful initial pharmacological treatment.

Akechi T, Mantani A, Kurata K, Hirota S, Shimodera S, Yamada M, Inagaki M, Watanabe N, Kato T, Furukawa TA; SUND Investigators.

J Affect Disord. 2019 May 1;250:108-113. doi: 10.1016/j.jad.2019.03.004. Epub 2019 Mar 5.

PMID:
30851699
41.

Dismantling, personalising and optimising internet cognitive-behavioural therapy for depression: a study protocol for individual participant data component network meta-analysis.

Furukawa TA, Karyotaki E, Suganuma A, Pompoli A, Ostinelli EG, Cipriani A, Cuijpers P, Efthimiou O.

BMJ Open. 2019 Feb 22;8(11):e026137. doi: 10.1136/bmjopen-2018-026137.

42.

Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study.

Imai F, Momino K, Katsuki F, Horikoshi M, Furukawa TA, Kondo N, Toyama T, Yamaguchi T, Akechi T.

Jpn J Clin Oncol. 2019 Jun 1;49(6):537-544. doi: 10.1093/jjco/hyz005.

PMID:
30793156
43.

Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.

Noma H, Maruo K, Gosho M, Levine SZ, Goldberg Y, Leucht S, Furukawa TA.

BMC Med Res Methodol. 2019 Feb 14;19(1):33. doi: 10.1186/s12874-019-0676-1.

44.

Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov.

Takeshima N, Ishiwata K, Sozu T, Furukawa TA.

Alzheimer Dis Assoc Disord. 2019 Feb 5. doi: 10.1097/WAD.0000000000000297. [Epub ahead of print]

PMID:
30730347
45.

Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: A secondary analysis of a randomized controlled trial.

Tsujimoto Y, Aoki T, Shinohara K, So R, Suganuma AM, Kimachi M, Yamamoto Y, Furukawa TA.

PLoS One. 2019 Jan 25;14(1):e0211206. doi: 10.1371/journal.pone.0211206. eCollection 2019.

46.

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.

Shinohara K, Tanaka S, Imai H, Noma H, Maruo K, Cipriani A, Yamawaki S, Furukawa TA.

Evid Based Ment Health. 2019 Feb;22(1):10-16. doi: 10.1136/ebmental-2018-300073. Epub 2019 Jan 21.

PMID:
30665989
47.

Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.

Yamamoto-Sasaki M, Yoshida S, Takeuchi M, Tanaka-Mizuno S, Ogawa Y, Furukawa TA, Kawakami K.

Matern Health Neonatol Perinatol. 2019 Jan 10;5:1. doi: 10.1186/s40748-018-0096-y. eCollection 2019.

48.

Maternal diabetes in early pregnancy, and psychotic experiences and depressive symptoms in 10-year-old offspring: A population-based birth cohort study.

Yamasaki S, Ando S, Richards M, Hatch SL, Koike S, Fujikawa S, Kanata S, Endo K, Morimoto Y, Arai M, Okado H, Usami S, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K, Nishida A.

Schizophr Res. 2019 Apr;206:52-57. doi: 10.1016/j.schres.2018.12.016. Epub 2018 Dec 26.

49.

Response inhibition and anxiety in adolescents: Results from a population-based community sample.

Iijima Y, Okumura Y, Yamasaki S, Ando S, Nakanishi M, Koike S, Endo K, Morimoto Y, Kanata S, Fujikawa S, Yamamoto Y, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K, Nishida A.

J Affect Disord. 2019 Mar 1;246:89-95. doi: 10.1016/j.jad.2018.12.010. Epub 2018 Dec 10.

PMID:
30578951
50.

Predictors of hypomanic and/or manic switch among patients initially diagnosed with unipolar major depression during acute-phase antidepressants treatment.

Akechi T, Kato T, Watanabe N, Tanaka S, Furukawa TA; SUN☺D Investigators.

Psychiatry Clin Neurosci. 2019 Feb;73(2):90-91. doi: 10.1111/pcn.12808. Epub 2019 Jan 6. No abstract available.

PMID:
30537349

Supplemental Content

Loading ...
Support Center